PT-141 (Bremelanotid)
A melanocortin agonist acting via the central nervous system, not vascularly.
PT-141 is a selective agonist of the MC3R and MC4R receptors. The key difference from vasodilators: it does not act on blood vessels but directly via the central nervous system.
It is the primary research peptide for investigating sexual dysfunction in men and women — specifically the mechanisms of stimulation in desire disorders (HSDD) and erectile dysfunction.
Compound identity
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OHNle = norleucine, D-Phe = D-phenylalanine; cyclo[…] = lactam bridge between Asp and Lys. |
|---|---|
| Chain length | 7 amino acids |
| Molecular formula | C50H68N14O10 |
| Molecular weight | 1,025.16 g/mol |
| CAS number | 189691-06-3 |
| Data source | KEGG DRUG D06569 |
Available forms
- PT-141 10 mg (vial)€28.90
- PT-141 10 mg (pen)Coming soon
Article about this compound
← All compounds in the glossary
This information is strictly educational and summarises publicly available research. It is not medical advice. All compounds are intended exclusively for laboratory and research purposes, are not medicines or food supplements, and are not intended for human consumption.